USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells-Reference-Cited by-同舟云学术

USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells

Published:2018-11-08 Issue:1 Volume:16 Page:
ISSN:1478-811X
Container-title:Cell Communication and Signaling
language:en
Short-container-title:Cell Commun Signal

Author:

McCann Aidan P.,Smyth Peter,Cogo Francesco,McDaid William J.,Jiang Lai,Lin Jia,Evergren Emma,Burden Roberta E.,Van Schaeybroeck Sandra,Scott Christopher J.,Burrows James F.^ORCID

Funder

Biotechnology and Biological Sciences Research Council

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

http://link.springer.com/content/pdf/10.1186/s12964-018-0291-5.pdf

Reference36 articles.

1. Komander D, Rape M. The ubiquitin code. Annu Rev Biochem. 2012;81:203–29.

2. Leznicki P, Kulathu Y. Mechanisms of regulation and diversification of deubiquitylating enzyme function. J Cell Sci. 2017;130:1997–2006.

3. Zhu Y, Pless M, Inhorn R, Mathey-Prevot B, D’Andrea a D. The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. Mol Cell Biol. 1996;16:4808–17.

4. Zhu Y, Lambert K, Corless C, Copeland NG, Gilbert DJ, Jenkins NA, et al. DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. J Biol Chem. 1997;272:51–7.

5. Burrows JF, McGrattan MJ, Rascle A, Humbert M, Baek KH, Johnston JA. DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. J Biol Chem. 2004;279:13993–4000.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging roles of deubiquitinating enzymes in actin cytoskeleton and tumor metastasis;Cellular Oncology;2024-02-07

2. Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy;Frontiers in Pharmacology;2023-12-05

3. Deubiquitinase USP17 Regulates Osteoblast Differentiation by Increasing Osterix Protein Stability;International Journal of Molecular Sciences;2023-10-17

4. EGFR-T790M Mutation–Derived Interactome Rerouted EGFR Translocation Contributing to Gefitinib Resistance in Non-Small Cell Lung Cancer;Molecular & Cellular Proteomics;2023-09

5. Protein degradation: expanding the toolbox to restrain cancer drug resistance;Journal of Hematology & Oncology;2023-01-24